Status:
COMPLETED
Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis
Lead Sponsor:
Regional Hospital Holstebro
Conditions:
Liver Cirrhosis
Eligibility:
All Genders
20-60 years
Phase:
PHASE1
Brief Summary
Phase 1 study of the effects of nitric oxide inhibition with L-NMMA in patients with liver cirrhosis and healthy controls. It is hypothesized that nitric oxide availability is increased in liver cirrh...
Detailed Description
In a randomized, placebo controlled design the acute effects of Ng-monomethyl-L-arginine are studied on: * renal hemodynamics (GFR and RPF) * blood pressure and heart rate * lithium clearance * plasm...
Eligibility Criteria
Inclusion
- Healthy controls
- Age 20 to 60 years
- Both men and women
- Weight below 100 kg
- Normal clinical examination and laboratory screening
- Fertile women only if using contraception
- Informed consent according to the regulations of the local ethics committee
- Liver cirrhosis
- Biopsy verified liver cirrhosis or clinical and laboratory signs of liver cirrhosis including hypoalbuminaemia, increased prothrombin time in combination with esophagusvarices or ascites
- P-creatinine \< 250 µmol/L
- Age 20-60 years
- Both men and women
- Fertile women only if using contraception
- Body weight below 100 kg
- Informed consent according to the regulations of the local ethics committee
Exclusion
- Healthy controls
- History or clinical evidence of diseases of the heart and blood vessels, kidneys, liver and pancreas, endocrine organs, lungs, neoplastic disease, myocardial infarction or cerebrovascular insult as evaluated by clinical examination and laboratory screening
- Current medication
- Drugs or alcohol abuse
- Pregnancy
- Previously within one year received more than 0.2 mSV radioactive treatment or diagnostic substances
- Donation of blood less than 1 month before the experiments
- Liver cirrhosis
- Apart from liver cirrhosis no history of diseases of the heart and blood vessels, endocrine organs, lungs, myocardial infarction, cerebrovascular insult or neoplastic disease.
- Drugs or alcohol abuse
- Pregnancy
- Previously within one year received more than 0.2 mSV radioactive treatment or diagnostic substances
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00344916
Last Update
July 11 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.